Szanowni Państwo,
Klaster MedSilesia od kwietnia stał się członkiem stowarzyszenia CEBR - Council of European Bioregions. CEBR daje nam szansę nawiązania wartościowych kontaktów, realizację wspólnych przedsięwzięć, ale też możliwości udziału w branżowych wydarzeniach, o których na bieżąco będziemy Państwa informować.
Zgodnie z informacją od organizatorów jest możliwość udziału online.
Życzę dobrego dnia, a poniżej treść otrzymanego zaproszenia:
Vall d’Hebron Institute of Research has the pleasure to invite you to attend a Workshop on Hyperthermic Oncology, a one-day event that will take place on the 9th of June in the Hotel Front Marítim in Barcelona, from 09:00 to 16:30 CEST.
The workshop, organised by VHIR within the frame of the European project Safe-N-MedTech, in which CEBR is a partner, aims to encourage a better understanding and acceptance of different modalities of hyperthermia in oncological treatments.
During the different sessions, both clinical and regulatory aspects will be covered:
- Morning session: relevant speakers will give us an overview of the current situation and the different modalities of hyperthermic oncology in Spain and Europe. Particularly, with a special focus on magnetic hyperthermia and pancreatic cancer in Spain.
- Afternoon session: regulatory requirements for approval of nanotechnologies through the European Regulation and the Spanish regulatory authorities will be addressed.
This is a great opportunity to listen an amazing panel of experts:
- Jorge Contreras (Coordinator of Spanish Society of Radiation Oncology)
- Teresa Macarulla (Oncologist and Clinical leader of the NoCanTher Clinical Investigation)
- Giammaria Fiorentini (Consultant for Locoregional treatments and Hyperthermia, Rete Oncologica della Regione Toscana, Firenze, Italy)
- Daniel Ortega (Coordinator of the national network of Nanotechnology in Translational Hyperthermia)
- Álvaro Somoza (Research Professor at IMDEA NanoScience)
- Julia Caro-Barri (Chief of the National Center of Certifications of Medical Devices in Spain)
- David Tomé (Head of Clinical Operations and Medical writing at Mdx)
- Luc Van Hove (Expert in Medical, Regulatory and Clinical Affairs)
- Ibane Abasolo (Head of Drug Delivery and Targeting Group at VHIR)
- Adriele Prina-Mello (LBCAM Director at Trinity Translational Medicine Institute)
Full programme attached!
To register for FREE, please access the following LINK * (online connection available upon request)
*Coffee breaks and lunch are included.
